Home > Healthcare > Healthcare IT > Artificial Intelligence > Generative AI in Healthcare Market
Generative Artificial Intelligence (AI) in Healthcare Market size was valued at USD 1.8 billion in 2023 and is expected to reach USD 22.1 billion by end of 2032 growing at a CAGR of 32.6% over the analysis period. The surging demand for AI in healthcare stemmed from the transformative impact in healthcare industry revolutionizing medical practices, enhancing efficiency, and improving patient outcomes.
The market has been attracted to generative AI due to its capacity to create reliable and innovative data, thereby improving diagnostics, replicating patient responses, and providing synthetic datasets for testing and training purposes. As reported in the article 2024 Life Sciences and Health Care Generative AI Outlook Survey, the healthcare industry is investing heavily in exposing the transformative possibilities of generative AI, with approximately 75% of major healthcare companies currently experimenting or planning to scale generative AI. Thus, the increasing traction for generative AI is opening up new opportunities in the healthcare sector.
Generative AI in healthcare refers to the application of artificial intelligence (AI) techniques that involve the generation of new and original data. Also, in the healthcare sector, generative AI is used for tasks such as generating synthetic medical images, creating virtual patient data for training healthcare algorithms, simulating disease progression, and even designing novel molecules for drug discovery.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
Generative AI in Healthcare Market Size in 2023: | USD 1.8 Billion |
Forecast Period: | 2024 to 2032 |
Forecast Period 2024 to 2032 CAGR: | 32.6% |
2032 Value Projection: | USD 22.1 Billion |
Historical Data for: | 2018 to 2023 |
No. of Pages: | 120 |
Tables, Charts & Figures: | 195 |
Segments covered: | Application, End-use, & Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|